These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11332946)

  • 1. Dietary intervention in the first four years prevents abnormal weight gain but negatively affects height development in Prader-Willi syndrome.
    Schmidt H; Schwarz HP; Enders A
    Acta Paediatr; 2001 Apr; 90(4):468-9. PubMed ID: 11332946
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth in the Prader-Willi syndrome.
    Holm VA; Nugent JK
    Birth Defects Orig Artic Ser; 1982; 18(3B):93-100. PubMed ID: 7139117
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
    Eiholzer U; Meinhardt U; Gallo C; Schlumpf M; Rousson V; l'Allemand D
    J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standards for selected anthropometric measurements in Prader-Willi syndrome.
    Butler MG; Meaney FJ
    Pediatrics; 1991 Oct; 88(4):853-60. PubMed ID: 1896298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular histology in boys with Prader-Willi syndrome: fertile or infertile?
    Vogels A; Moerman P; Frijns JP; Bogaert GA
    J Urol; 2008 Oct; 180(4 Suppl):1800-4. PubMed ID: 18721940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
    Eiholzer U; Schlumpf M; Nordmann Y; l'Allemand D
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prader-Willi syndrome in young infants].
    Pronk E; Braam W
    Ned Tijdschr Geneeskd; 1998 Jan; 142(3):155. PubMed ID: 9557017
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality of life assessment in a sample of patients affected by Prader-Willi syndrome.
    Caliandro P; Grugni G; Padua L; Kodra Y; Tonali P; Gargantini L; Ragusa L; Crinò A; Taruscio D
    J Paediatr Child Health; 2007 Dec; 43(12):826-30. PubMed ID: 17803668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of adiposity in Prader-Labhart-Willi syndrome].
    Naselli A; Vignolo M; Di Battista E; de Toni T; Aicardi G
    Minerva Pediatr; 1983 Jun; 35(11):579-85. PubMed ID: 6621511
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth and developmental patterns in Prader-Willi syndrome.
    Ehara H; Ohno K; Takeshita K
    J Intellect Disabil Res; 1993 Oct; 37 ( Pt 5)():479-85. PubMed ID: 8268714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics, diagnosis, and management of Prader-Willi syndrome.
    Nativio DG
    J Pediatr Health Care; 2002; 16(6):298-303. PubMed ID: 12436099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prader-Willi syndrome].
    Mochizuki H; Usui N
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):494-6. PubMed ID: 9277975
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain developmental abnormalities in Prader-Willi syndrome detected by diffusion tensor imaging.
    Yamada K; Matsuzawa H; Uchiyama M; Kwee IL; Nakada T
    Pediatrics; 2006 Aug; 118(2):e442-8. PubMed ID: 16882785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prader-Willi syndrome: an update and review for the primary pediatrician.
    Chen C; Visootsak J; Dills S; Graham JM
    Clin Pediatr (Phila); 2007 Sep; 46(7):580-91. PubMed ID: 17522286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone in Prader-Willi syndrome. A case report.
    Ruvalcaba RH; Holm VA
    Clin Pediatr (Phila); 1993 May; 32(5):292-5. PubMed ID: 8324972
    [No Abstract]   [Full Text] [Related]  

  • 20. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
    Tauber M; Cutfield W
    Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.